Exp Neurol, 2008 · DOI: 10.1016/j.expneurol.2007.08.004 · Published: February 1, 2008
The adult mammalian spinal cord does not regenerate after injury, unlike the peripheral nervous system. Researchers have been exploring ways to enhance axonal growth in the injured central nervous system using therapies such as neurotrophic factors. Combination therapies that target distinct neural mechanisms appear to be more effective in promoting axonal growth than single therapies applied in isolation. To achieve substantial axonal growth in the injured adult CNS, multiple mechanisms need to be addressed simultaneously because axonal elongation during development depends on a combination of events.
Future therapies for spinal cord injury should focus on combining multiple approaches to address the complex nature of axonal regeneration.
Understanding the specific effects of different growth factors on different axon types can help design targeted therapies.
Systematic examination of combinatorial approaches in animal models is necessary before translating them to human clinical trials.